药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tasosartan
Nabiximols
Nabiximols may decrease the excretion rate of Palbociclib which could result in a higher serum level.
Tasosartan
Avatrombopag
Avatrombopag may decrease the excretion rate of Palbociclib which could result in a higher serum level.
Tasosartan
Paritaprevir
Paritaprevir may decrease the excretion rate of Palbociclib which could result in a higher serum level.
Tasosartan
Rolapitant
Rolapitant may decrease the excretion rate of Palbociclib which could result in a higher serum level.
Tasosartan
Dasabuvir
Dasabuvir may decrease the excretion rate of Palbociclib which could result in a higher serum level.
Tasosartan
Daclatasvir
Daclatasvir may decrease the excretion rate of Palbociclib which could result in a higher serum level.
Tasosartan
Pibrentasvir
Palbociclib may decrease the excretion rate of Pibrentasvir which could result in a higher serum level.
Tasosartan
Lusutrombopag
Palbociclib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.
Tasosartan
Voxilaprevir
Palbociclib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Tasosartan
Glasdegib
Palbociclib may decrease the excretion rate of Glasdegib which could result in a higher serum level.
Tasosartan
Delafloxacin
Palbociclib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tasosartan
Revefenacin
Palbociclib may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Tasosartan
Ertugliflozin
Palbociclib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Tasosartan
Velpatasvir
Palbociclib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.
Tasosartan
Ombitasvir
Palbociclib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.
Tasosartan
Fimasartan
Palbociclib may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Tasosartan
Adenovirus type 7 vaccine live
The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Palbociclib.
Tasosartan
Vibrio cholerae CVD 103-HgR strain live antigen
The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Palbociclib.
Tasosartan
Human adenovirus e serotype 4 strain cl-68578 antigen
The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Palbociclib.
Tasosartan
BCG vaccine
The risk or severity of infection can be increased when BCG vaccine is combined with Palbociclib.